Impact of Kidney Failure on the Severity of COVID-19

Background: Patients with kidney failure are at an increased risk of progression to a severe form of coronavirus disease 2019 (COVID-19) with high mortality. The current analysis was aimed to assess the impact of renal failure on the severity of COVID-19 and identify the risk factors of the fatal ou...

Full description

Bibliographic Details
Main Authors: Dorota Zarębska-Michaluk, Jerzy Jaroszewicz, Magdalena Rogalska, Beata Lorenc, Marta Rorat, Anna Szymanek-Pasternak, Anna Piekarska, Aleksandra Berkan-Kawińska, Katarzyna Sikorska, Magdalena Tudrujek-Zdunek, Barbara Oczko-Grzesik, Beata Bolewska, Piotr Czupryna, Dorota Kozielewicz, Justyna Kowalska, Regina Podlasin, Krzysztof Kłos, Włodzimierz Mazur, Piotr Leszczyński, Bartosz Szetela, Katarzyna Reczko, Robert Flisiak
Format: Article
Language:English
Published: MDPI AG 2021-05-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/10/9/2042
Description
Summary:Background: Patients with kidney failure are at an increased risk of progression to a severe form of coronavirus disease 2019 (COVID-19) with high mortality. The current analysis was aimed to assess the impact of renal failure on the severity of COVID-19 and identify the risk factors of the fatal outcome in this population. Methods: The analysis included patients from the SARSTer database, a national real-world study evaluating treatment for COVID-19 in 30 Polish centers. Data were completed retrospectively and submitted online. Results: A total of 2322 patients were included in the analysis. Kidney failure was diagnosed in 455 individuals (19.65%), of whom 373 presented moderate stage and 82 patients, including 14 dialysis individuals, presented severe renal failure. Patients with kidney failure were significantly older and demonstrated a more severe course of COVID-19. The age, baseline SpO<sub>2</sub>, the ordinal scale of 4 and 5, neutrophil and platelet count, estimated glomerular filtration rate, and C-reactive protein concentration as well as malignancy and arterial hypertension were the independent predictors of 28-day mortality in logistic regression analysis. Conclusions: Underlying kidney disease in patients with COVID-19 is among the leading factors associated with a higher risk of severe clinical presentation and increased mortality rate.
ISSN:2077-0383